These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. McKenzie R, Kovac A, O'Connor T, Duncalf D, Angel J, Gratz I, Tolpin E, McLeskey C, Joslyn A. Anesthesiology; 1993 Jan; 78(1):21-8. PubMed ID: 8424561 [Abstract] [Full Text] [Related]
28. The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting. Chen X, Tang J, White PF, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E. Anesth Analg; 2001 Oct; 93(4):906-11. PubMed ID: 11574355 [Abstract] [Full Text] [Related]
31. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, Elhattab YS, Attia M, Jaroudi R, Saddique A. Can J Anaesth; 1996 Mar; 43(3):226-31. PubMed ID: 8829860 [Abstract] [Full Text] [Related]
32. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding. McKenzie R, Uy NT, Riley TJ, Hamilton DL. Anesth Analg; 1996 Dec; 83(6):1218-22. PubMed ID: 8942589 [Abstract] [Full Text] [Related]
33. Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial. Bergese S, Viloria A, Uribe A, Antor A, Fernandez S. Trials; 2012 Aug 03; 13():130. PubMed ID: 22862827 [Abstract] [Full Text] [Related]
34. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children. Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E. Anesth Analg; 2002 Nov 03; 95(5):1230-5, table of contents. PubMed ID: 12401599 [Abstract] [Full Text] [Related]
35. Ondansetron versus droperidol or placebo to prevent nausea and vomiting after otologic surgery. Jellish WS, Leonetti JP, Fluder E, Thalji Z. Otolaryngol Head Neck Surg; 1998 Jun 03; 118(6):785-9. PubMed ID: 9627237 [Abstract] [Full Text] [Related]
36. A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients. McKenzie R, Sharifi-Azad S, Dershwitz M, Miguel R, Joslyn AF, Tantisira B, Rosenblum F, Rosow CE, Downs JB, Bowie JR. J Clin Anesth; 1993 Jun 03; 5(1):30-6. PubMed ID: 8442964 [Abstract] [Full Text] [Related]
37. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery. Krobbuaban B, Pitakpol S, Diregpoke S. J Med Assoc Thai; 2008 May 03; 91(5):669-74. PubMed ID: 18672630 [Abstract] [Full Text] [Related]
38. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. Fox-Geiman MP, Fisher SG, Kiley K, Fletcher-Gonzalez D, Porter N, Stiff P. Biol Blood Marrow Transplant; 2001 May 03; 7(11):596-603. PubMed ID: 11760147 [Abstract] [Full Text] [Related]